TC Biopharm are leading the way in the future treatment of cancer and infectious diseases as pioneers of the first scalable "off the shelf" allogeneic gamma delta T cell therapy platform. They are developing safer, efficacious, cost-effective cell therapy products which can target more cancers and infectious disease and save more lives.